Torthaí cuardaigh - Robert E. Martell

  • 1 - 12 toradh as 12 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    1,25-Dihydroxyvitamin D3 regulation of phorbol ester receptors in HL-60 leukemia cells.

    1,25-Dihydroxyvitamin D3 regulation of phorbol ester receptors in HL-60 leukemia cells. de réir Robert E. Martell, Robert U. Simpson, Jennifer M. Taylor

    Foilsithe / Cruthaithe 1987
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    PS991 CA‐4948, AN IRAK4/FLT3 INHIBITOR, SHOWS ANTILEUKEMIC ACTIVITY IN MOUSE MODELS OF FLT3 WILD‐TYPE AND FLT3 MUTATED ACUTE MYELOID LEUKEMIA (AML)

    PS991 CA‐4948, AN IRAK4/FLT3 INHIBITOR, SHOWS ANTILEUKEMIC ACTIVITY IN MOUSE MODELS OF FLT3 WILD‐TYPE AND FLT3 MUTATED ACUTE MYELOID LEUKEMIA (AML) de réir Robert Booher, Maria Samson, Mikołaj Borek, Holly A. Modafferi, Robert E. Martell

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism

    The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism de réir Daniela Buglio, Vidya Mamidipudi, Noor M. Khaskhely, Helen Brady, Carla Heise, Jeffrey M. Besterman, Robert E. Martell, Kyle J. MacBeth, Anas Younes

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay

    Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay de réir Claire Bonfils, Ann Kalita, Marja Dubay, Lillian L. Siu, Michael A. Carducci, Gregory K. Reid, Robert E. Martell, Jeffrey M. Besterman, Zuomei Li

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    VISTA expression and patient selection for immune-based anticancer therapy

    VISTA expression and patient selection for immune-based anticancer therapy de réir Alexander S. Martin, Michael Molloy, Andrey Ugolkov, Reinhard W. Von Roemeling, Randolph J. Noelle, Lionel D. Lewis, Melissa L. Johnson, Laszlo Radvanyi, Robert E. Martell

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Diabetes, metformin use, and colorectal cancer survival in postmenopausal women

    Diabetes, metformin use, and colorectal cancer survival in postmenopausal women de réir Furha Cossor, Lucile L. Adams‐Campbell, Rowan T. Chlebowski, Marc J. Gunter, Karen Johnson, Robert E. Martell, Anne McTiernan, Michael S. Simon, Thomas E. Rohan, Robert B. Wallace, Jessica K. Paulus

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

    Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia de réir Kristie A. Blum, Anjani Advani, Louis A. Fernandez, Richard van der Jagt, Joseph Brandwein, Suman Kambhampati, Jeannine Kassis, Melanie E. Davis, Claire Bonfils, Marja Dubay, Julie Dumouchel, Michel Drouin, David Lucas, Robert E. Martell, John C. Byrd

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors

    Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors de réir Lillian L. Siu, Роберто Пили, Ignacio Durán, Wells A. Messersmith, Eric X. Chen, Rana Sullivan, Martha MacLean, Serina King, Shirley Brown, Gregory K. Reid, Zuomei Li, Ann Kalita, Eric Laille, Jeffrey M. Besterman, Robert E. Martell, Michael A. Carducci

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

    Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors de réir Igor Puzanov, Jeffrey A. Sosman, Armando Santoro, Muhammad Wasif Saif, Laura W. Goff, Grace K. Dy, Paolo Andrea Zucali, Julie A. Means‐Powell, Wen Wee, Matteo Simonelli, Robert E. Martell, Feng Chai, Maria Lamar, Ronald E. Savage, Brian Schwartz, Alex A. Adjei

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial

    Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial de réir Anas Younes, Yasuhiro Oki, R. Gregory Bociek, John Kuruvilla, Michelle A. Fanale, Sattva S. Neelapu, Amanda Copeland, Daniela Buglio, Ahmed Galal, Jeffrey M. Besterman, Zuomei Li, Michel Drouin, Tracy Patterson, M. Renee Ward, Jessica K. Paulus, Yuan Ji, L. Jeffrey Medeiros, Robert E. Martell

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia de réir Guillermo Garcia‐Manero, Sarit Assouline, Jorge E. Cortés, Zeev Estrov, Hagop M. Kantarjian, Hui Yang, Willie Newsome, Wilson H. Miller, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, T. Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Eric Laille, Robert E. Martell, Mark D. Minden

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations

    Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations de réir Gaurav S. Choudhary, Andrea Pellagatti, Bogos Agianian, Molly A. Smith, Tushar D. Bhagat, Shanisha Gordon-Mitchell, Srabani Sahu, Sanjay Pandey, Nishi Shah, Srinivas Aluri, Ritesh K. Aggarwal, Sarah Aminov, Leya Schwartz, Violetta Steeples, Robert N. Booher, Murali Ramachandra, Maria Samson, Milagros Carbajal, Kith Pradhan, Teresa V. Bowman, Manoj M. Pillai, Britta Will, Amittha Wickrema, Aditi Shastri, Robert K. Bradley, Robert E. Martell, Ulrich Steidl, Evripidis Gavathiotis, Jacqueline Boultwood, Daniel T. Starczynowski, Amit Verma

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: